Marc S Ernstoff Selected Research

Glioblastoma (Glioblastoma Multiforme)

3/2017	Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.
7/2013	Vaccine-based immunotherapy for glioblastoma.
1/2012	Immunotherapy for the treatment of glioblastoma.
5/2011	Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.
4/2011	Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc S Ernstoff Research Topics

Disease

81	Neoplasms (Cancer) 04/2024 - 05/2002
58	Melanoma (Melanoma, Malignant) 04/2024 - 03/2002
26	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 09/2002
10	Neoplasm Metastasis (Metastasis) 08/2018 - 03/2002
7	Brain Neoplasms (Brain Tumor) 12/2021 - 10/2008
6	Disease Progression 12/2021 - 05/2006
5	Colitis 12/2021 - 01/2016
5	Glioblastoma (Glioblastoma Multiforme) 03/2017 - 04/2011
4	Diarrhea 01/2023 - 12/2010
4	Exanthema (Rash) 01/2023 - 05/2012
4	Carcinoma (Carcinomatosis) 10/2018 - 04/2003
4	Prostatic Neoplasms (Prostate Cancer) 03/2013 - 05/2006
3	Fatigue 01/2023 - 05/2012
3	Cardiotoxicity 12/2021 - 10/2018
3	Inflammation (Inflammations) 01/2021 - 01/2012
3	Kidney Neoplasms (Kidney Cancer) 06/2007 - 09/2006
3	Leukemia 09/2006 - 04/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 01/2021
2	Hypophysitis 12/2021 - 11/2016
2	Neurologic Manifestations (Neurological Manifestations) 11/2021 - 08/2018
2	Myocarditis (Carditis) 01/2021 - 01/2019
2	Vitiligo 01/2021 - 05/2011
2	Body Weight (Weight, Body) 08/2018 - 05/2015
2	Colorectal Neoplasms (Colorectal Cancer) 05/2018 - 11/2010
2	Nevus (Nevi) 12/2016 - 09/2002
2	Human Influenza (Influenza) 11/2008 - 05/2003
1	Anemia 01/2023
1	Dysgeusia (Parageusia) 01/2023
1	Edema (Dropsy) 01/2023
1	Stomatitis 01/2023
1	Hypophosphatemia 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

23	Interleukin-2 (IL2)IBA 04/2024 - 01/2003
16	CytokinesIBA 04/2024 - 04/2003
15	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2018
12	VaccinesIBA 12/2020 - 03/2004
10	NivolumabIBA 12/2021 - 05/2015
9	Biomarkers (Surrogate Marker)IBA 06/2023 - 12/2006
9	IpilimumabIBA 12/2021 - 05/2012
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
7	Peptides (Polypeptides)IBA 12/2015 - 05/2003
6	pembrolizumabIBA 01/2021 - 05/2018
6	AntigensIBA 10/2020 - 04/2003
5	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2018
5	LigandsIBA 01/2022 - 01/2017
5	Temozolomide (Temodar)FDA LinkGeneric 03/2017 - 10/2008
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2015 - 04/2003
5	InterferonsIBA 01/2012 - 03/2004
4	Sunitinib (Sutent)FDA Link 01/2023 - 12/2011
4	VemurafenibIBA 11/2020 - 04/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 02/2009
4	Sorafenib (BAY 43-9006)FDA Link 01/2014 - 03/2007
3	Formaldehyde (Formol)FDA Link 01/2023 - 01/2018
3	ParaffinIBA 01/2023 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2002
3	Alanine Transaminase (SGPT)IBA 12/2021 - 11/2016
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2015 - 01/2006
3	aldesleukin (Proleukin)FDA Link 02/2015 - 06/2007
3	Cancer VaccinesIBA 03/2008 - 03/2004
3	Interferon alpha-2 (Roferon-A)FDA Link 05/2007 - 03/2002
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	B7-H1 AntigenIBA 01/2023 - 02/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 11/2021
2	SteroidsIBA 11/2021 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2021
2	Troponin IIBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 07/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 01/2016
2	Imatinib Mesylate (Gleevec)FDA Link 11/2019 - 09/2013
2	pazopanib FDA Link 03/2019 - 10/2018
2	Interleukin-15 (Interleukin 15)IBA 11/2018 - 11/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018 - 01/2016
2	Gemcitabine FDA Link 09/2017 - 09/2006
2	Mitogen-Activated Protein KinasesIBA 01/2016 - 03/2007
2	PlatinumIBA 04/2014 - 12/2006
2	Phosphotransferases (Kinase)IBA 04/2014 - 03/2007
2	interleukin-21 (interleukin 21)IBA 01/2014 - 11/2009
2	Bevacizumab (Avastin)FDA Link 11/2013 - 03/2010
2	AndrogensIBA 03/2013 - 12/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 09/2011 - 12/2006
2	Coloring Agents (Dyes)IBA 11/2008 - 01/2007
2	EpitopesIBA 07/2008 - 01/2006
2	Interferon-alpha (Interferon Alfa)IBA 01/2003 - 09/2002
1	CollagenIBA 02/2023
1	IntegrinsIBA 02/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	CreatinineIBA 01/2023
1	temsirolimus FDA Link 01/2023
1	Nucleic AcidsIBA 01/2023
1	NucleotidesIBA 01/2023

Therapy/Procedure

55	Therapeutics 06/2023 - 01/2003
28	Immunotherapy 04/2024 - 09/2005
7	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
4	Radiotherapy 05/2011 - 03/2007
3	Precision Medicine 01/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2016 - 11/2014
2	Injections 11/2010 - 03/2004
2	Biological Therapy 09/2007 - 03/2004
2	Drug Tapering 03/2007 - 09/2006